Engineered neural tissue made using clinical-grade human neural stem cells supports regeneration in a long gap peripheral nerve injury model
Source abstract
Abstract
A surgical autograft remains the clinical gold-standard therapy for gap repair following peripheral nerve injury, however, challenges remain with achieving full recovery and reducing donor-site morbidity. Engineered Neural Tissue (EngNT) manufactured using differentiated CTX0E03 human stem cells (EngNT-CTX) has been developed as a potential 'off the shelf' allogeneic autograft replacement. Ensheathed within a collagen membrane developed to facilitate biomechanical integration, EngNT-CTX was used to bridge a critical-length (15 mm) sciatic nerve gap injury in athymic nude rats. The effectiveness of EngNT-CTX was compared to an autograft using outcome measures that assessed neuronal regeneration and functional recovery at 8 and 16 weeks. At both time points EngNT-CTX restored electrophysiological nerve conduction and functional reinnervation of downstream muscles to the same extent as the autograft. Histological analysis confirmed that more motor neurons had successfully regenerated through the repair in EngNT-CTX in comparison to the autograft at 8 weeks, which was consistent with the electrophysiology, with the number of motor neurons similar in both groups by 16 weeks. The total number of neurons (motor + sensory) was greater in autografts than EngNT-CTX at 8 weeks, indicating that more sensory fibres may have sprouted in those animals at this time point. In conclusion, this study provides evidence to support the effectiveness of EngNT-CTX as a replacement for the nerve autograft, as the functional regeneration assessed through histological and electrophysiological outcome measures demonstrated equivalent performance. STATEMENT OF SIGNIFICANCE: Following injury a peripheral nerve has the capacity to regenerate naturally, however, in the case of severe damage where there is a gap the current gold-standard microsurgical intervention is an autograft. This is associated with serious limitations including tissue availability and donor-site morbidity. Tissue engineering aims to overcome these limitations by building a construct from therapeutic cells and biomaterials as a means to mimic and replace the autograft. In this study engineered neural tissue (EngNT) was manufactured using human stem cells (CTX) to bridge a critical-length gap injury. When compared to the autograft in an animal model the EngNT-CTX construct restored function to an equivalent or greater extent.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nerve injury and regeneration · Tissue Engineering and Regenerative Medicine · Pluripotent Stem Cells Research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (32)
Show source-provided references
1. Repairing injured peripheral nerves: bridging the gap10.1016/j.pneurobio.2010.10.002 ↗
2. Introduction to special issue: challenges and opportunities for regeneration in the peripheral nervous system10.1016/j.expneurol.2009.12.001 ↗
3. Peripheral nerve regeneration: experimental strategies and future perspectives10.1016/j.addr.2014.11.010 ↗
4. Surgical repair in humans after traumatic nerve injury provides limited functional neural regeneration in adults10.1016/j.expneurol.2017.01.009 ↗
5. FDA approved guidance conduits and wraps for peripheral nerve injury: a review of materials and efficacy10.1016/j.injury.2010.12.030 ↗
6. Experimental and clinical evidence for use of decellularized nerve allografts in peripheral nerve gap reconstruction10.1089/ten.teb.2012.0275 ↗
7. An allogeneic 'off the shelf' therapeutic strategy for peripheral nerve tissue engineering using clinical grade human neural stem cells10.1038/s41598-018-20927-8 ↗
8. Allogenic benefit in stem cell therapy: cardiac repair and regeneration10.1111/tan.12614 ↗
9. Using stem cells to grow artificial tissue for peripheral nerve repair10.1155/2016/7502178 ↗
10. Risk factors in the development of stem cell therapy10.1186/1479-5876-9-29 ↗
11. The bioethics of stem cell research and therapy10.1172/JCI40435 ↗
12. A conditionally immortal clonal stem cell line from human cortical neuroepithelium for the treatment of ischemic stroke10.1016/j.expneurol.2005.12.011 ↗
13. Human neural stem cell therapy for chronic ischemic stroke: charting progress from laboratory to patients10.1089/scd.2017.0009 ↗
14. Clinical-grade human neural stem cells promote reparative neovascularization in mouse models of hindlimb ischemia10.1161/ATVBAHA.113.302592 ↗
15. Biomaterials for the development of peripheral nerve guidance conduits10.1089/ten.teb.2011.0240 ↗
16. Peripheral nerve conduit: materials and structures10.1021/acschemneuro.9b00203 ↗
17. Engineered neural tissue for peripheral nerve repair10.1016/j.biomaterials.2013.06.025 ↗
18. Engineered neural tissue with aligned, differentiated adipose-derived stem cells promotes peripheral nerve regeneration across a critical sized defect in rat sciatic nerve10.1016/j.biomaterials.2014.10.009 ↗
19. The effect of hypothermic and cryogenic preservation on engineered neural tissue10.1089/ten.tec.2017.0244 ↗
20. Schwann cells and mesenchymal stem cells in laminin- or fibronectin-aligned matrices and regeneration across a critical size defect of 15 mm in the rat sciatic nerve10.3171/2017.5.SPINE161100 ↗
21. An optimized collagen-fibrin blend engineered neural tissue promotes peripheral nerve repair10.1089/ten.tea.2017.0457 ↗
22. Human dental pulp stem cells can differentiate into Schwann cells and promote and guide neurite outgrowth in an aligned tissue-engineered collagen construct in vitro10.1096/fj.13-243980 ↗
23. Engineered neural tissue with schwann cell differentiated human dental pulp stem cells: potential for peripheral nerve repair?10.1002/term.2249 ↗
24. Optimising contraction and alignment of cellular collagen hydrogels to achieve reliable and consistent engineered anisotropic tissue10.1177/0885328215597818 ↗
25. Epineurial sheath tube (EST) technique: an experimental peripheral nerve repair model10.1179/1743132811Y.0000000029 ↗
26. Optimising contraction and alignment of cellular collagen hydrogels to achieve reliable and consistent engineered anisotropic tissue10.1177/0885328215597818 ↗
27. Developing an in Vitro model to screen drugs for nerve regeneration10.1002/ar.23918 ↗
28. The overwhelming use of rat models in nerve regeneration research may compromise designs of nerve guidance conduits for humans10.1007/s10856-015-5558-4 ↗
29. The relationship between nerve conduction velocity and fiber morphology during peripheral nerve regeneration10.1002/brb3.61 ↗
30. Regenerative effect of adipose tissue-derived stem cells transplantation using nerve conduit therapy on sciatic nerve injury in rats10.1002/term.1523 ↗
31. Superior muscle reinnervation after autologous nerve graft or poly-L-lactide-epsilon-caprolactone (PLC) tube implantation in comparison to silicone tube repair10.1002/1097-4547(20010115)63:2<214::AID-JNR1014>3.0.CO;2-D ↗
32. Neuronal differentiation of human adipose tissue-derived stem cells for peripheral nerve regeneration in vivo10.1001/archsurg.2011.148 ↗